Hypertension Mortality Rose Significantly from 1999 to 2019
With hypertension commonly leading to increased risk of mortality, researchers aimed to understand the hypertensive survival rates of patients with diabetes over a 20-year period.
Achieving PBM Reform Through Public Engagement, Advocacy
Regardless of which stakeholders are involved, a collective, team effort is necessary to achieve state- and federal-level PBM reform.
CVS, Walgreens Will Limit COVID-19 Vaccine Offerings in 16 States
CVS will not offer COVID-19 vaccines in Massachusetts, Nevada, and New Mexico.
Wegovy Outperforms Tirzepatide in Reducing Major Adverse Cardiovascular Events
A real-world study found that semaglutide significantly reduced the risk of major cardiovascular events compared to tirzepatide.
Community Health Programs Improved Outcomes Among Black Patients
Using results from the Rx for Change program in Pittsburgh, Pennsylvania, researchers explored an integrative approach to cardiometabolic disease management among Black patients.
FDA Approves Biosimilars for Prolia, Xgeva
The FDA approves denosumab-nxxp (Bildyos and Bilprevda), enhancing access to vital bone health treatments for osteoporosis and cancer-related conditions.
Prescription-to-OTC Switch of Triptans Showed Positive Public Health Impact
Detailing the public health impact of an Rx-to-OTC switch, researchers explored the reclassification of triptan medications in Germany.
Q&A: Equity in Pharmacy Means Meeting Patients Where They Are
Pharmacists advance equity by personalizing care and addressing health literacy to meet patients where they are.
FDA Approves Lecanemab Subcutaneous Formulation as Maintenance Dose for Alzheimer Disease
FDA approves Leqembi's subcutaneous formulation, enhancing accessibility for Alzheimer's treatment and paving the way for future combination therapies.
Q&A: How the PBM Step Process, Prior Authorization Impact Patient Access
From the perspective of someone directly impacted by PBM practices, Bil Schmidtknecht shares his insights into the ways PBMs affect patients’ access to medications.
Q&A: Pharmacist Advocates for Evidence-Based Immunization Guidelines For COVID-19 Vaccines
Pharmacists navigate complex immunization challenges and address parental concerns and misinformation while advocating for streamlined vaccine access and adherence to evolving guidelines.
The Differences Between the Big 3, Non-Traditional PBMs
After sharing his son’s tragic story, Bil Schmidtknecht discusses the common ways the Big 3 PBMs operate and how smaller organizations are on the rise, becoming unlikely competitors.
Pharmacists Navigate Shifting Vaccine Guidelines Amid Unprecedented Changes
Laura Knockel, PharmD, BCACP, emphasize the importance of evidence-based recommendations and reliable resources for parents.
Higher BMI Associated with Lower All-Cause Mortality
Researchers explored the association of body mass index and all-cause mortality rates among older adults undergoing major elective surgery.
Q&A: CDC Alters COVID-19 Recommendations, Leading to Confusion on Pediatric Vaccine Schedules
Childhood immunization guidance in the US faces confusion as the AAP and CDC diverge on COVID-19 vaccine recommendations, impacting parents and providers.
Q&A: Pharmacists at the Frontline of Health Literacy Challenges
Pharmacists are uniquely positioned to close health literacy gaps through clear communication and intentional patient education.
Q&A: How Tragedy is Forcing Change in the PBM Industry
Bil Schmidtknecht joined Drug Topics to share his son’s tragic story and how it motivated him to join the greater fight in putting the lives of patients at the forefront of health care.
ACIP and CDC Guidelines Prompt AAP to Update Immunization Schedule
Confusion arises as health organizations diverge on COVID-19 vaccine recommendations for children, highlighting the need for clear guidance and support.
Influenza Vaccine Rates Increased Among Black, Hispanic Older Adults
Among older adults with Medicare, researchers investigated national influenza vaccination patterns by race, education level, and rurality.
PCV10 Among Children Indirectly Protected Unvaccinated Adults
Researchers explored the impact of PCV10 on the distribution of invasive pneumococcal disease serotypes among patients in Lithuania.
Independent, Chain Pharmacy Turnover Reflects Retail Business Churn
Addressing the impacts on patients and the overall pharmacy market, Joey Mattingly, PharmD, MBA, PhD, discusses trends in pharmacies opening and closing across the country.
FDA Approves First Generic GLP-1 Liraglutide for Weight Loss
Liraglutide is the first glucagon-like peptide-1 to have a generic equivalent for both type 2 diabetes and obesity indications.
FDA Approves COVID-19 Vaccines for Patients 65 Years and Older
The approved vaccines include Novavax’s Nuvaxovid and Moderna’s Spikevax and mNexspike.
FDA Approves Updated 2025-2026 COVID-19 Vaccine for Patients 65 Years and Older
The approval covers Pfizer and BioNTech’s LP.8.1-adapted monovalent COVID-19 vaccine, which is also indicated for patients aged 5 to 64 with at least 1 underlying condition.
Microneedle-Based Vaccine Systems Emerging as Viable Future Option
Through considerations regarding cost, scalability, safety, and regulations, researchers provided an end-to-end perspective on microneedle-based vaccine strategies.
Q&A: Addressing Barriers to Social Care in Pharmacies
Pharmacies face time, workload, and sustainability challenges when integrating social care, but support and reimbursement can make these efforts viable.
Real-World Data Show Dapagliflozin, Empagliflozin Are Safe Options for Diabetes
However, caution with empagliflozin use should be taken for patients who were previously on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
The Caution Needed in Addressing US Pharmacy Closures
In part 3 of our interview with Joey Mattingly, PharmD, MBA, PhD, he discusses potential government policies for reducing pharmacy closures.
Making Health Literacy a Practical Goal in Pharmacy
Small, evidence-based steps, resource awareness, advocacy, and interprofessional training can make health literacy a practical and sustainable part of pharmacy practice.
Register Today: September 2025 Total Pharmacy Solutions Summit
The event will focus on patient access and education in pharmacy practice, featuring industry leaders providing actionable strategies and real-world solutions for independent pharmacies.
